ResoTher Pharma is pleased to announce that Paul Hargreaves, MSc, MBA will take on the role as Chief Development Officer with responsibility for the company´s clinical activities. Mr. Hargreaves is a pharma veteran and bring with him extensive experience with clinical development from a number of senior positions in global companies such as Pfizer, Quintiles (now IQvia) and Leo Pharma, where he last served as Vice President, Global Clinical Operations. The addition of Paul Hargreaves to our team represents as solid milestone on our journey to becoming a clinical-stage drug development company and his deep expertise and extensive network will by a major asset in ensuring success in our future clinical endeavors.
Paul Hargreaves joins ResoTher Pharma as Chief Development Officer
|Published on: Mar 1, 2019||